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Abstract
n-3 Highly unsaturated fatty acids (HUFA), are essential components of neuronal membranes and mediate a range of complex bioactive
properties including gene expression, myelination, cell-signalling and dopaminergic function. Deﬁcits in n-3 HUFA have been linked to
increased risks for addictive disorders, thus we posited that lower ﬁsh consumption would be associated with greater risks for perinatal
smoking among 9640 mothers enroled in the Avon Longitudinal Study of Parents and Children. We used univariable and multivariable
regression models to examine relationships between self-reported prenatal dietary intakes of n-3 HUFA-rich foods (ﬁsh and shellﬁsh) and
maternal smoking; outcomes included cessation and the number of cigarettes smoked per d. Both before and during pregnancy, there was
consistent evidence (P< 0·001) of protective ﬁsh intake–smoking associations; relative to mothers reporting no ﬁsh consumption, those who
reported some ﬁsh consumption (<340 g/week) and high ﬁsh consumption (340 g+/week) at 32 weeks of gestation showed lower likelihoods
of smoking (adjusted P values < 0·001). Respective OR for these relationships were 0·87 (95% CI 0·77, 0·97) and 0·73 (95% CI 0·61, 0·86).
Although the prevalence of smoking diminished, from a high of 31·6% (pre-pregnancy) to a low of 18·7% (second trimester), the magnitude of
ﬁsh intake–smoking associations remained stable following adjustment for confounders. These observations suggest that greater ﬁsh or n-3
HUFA consumption should be evaluated as an intervention to reduce or prevent smoking in randomised clinical trials.
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Maternal smoking during pregnancy is a common and well
recognised risk factor for a range of adverse health and devel-
opmental outcomes and of signiﬁcant interest to public health
policies and practices(1), including alterations in genetically
programmed brain development during fetal life(2). Smoking
rates differ according to maternal age and education/profession.
The Ofﬁce of National Statistics UK, estimated that up to
23% of women of reproductive age and approximately one in
ten babies were born to women who smoked in pregnancy for
2015(3). The Avon Longitudinal Study of Parents and Children
(ALSPAC) reported that women who smoked during the
ﬁrst trimester of pregnancy were 55% less likely than their
non-smoking peers to breastfeed and 40% less likely to parti-
cipate in employment, education or training-based opportu-
nities(4). Mothers who smoked during the ﬁrst trimester were
also 50% more likely than their non-smoking peers to be
depressed at 8 weeks postpartum and also had an 1·3-fold
higher likelihood of feeling poorly attached to, or hostile
toward, their children(4).
Tobacco smoke contains more than 500 compounds with
putative neurotoxic capacities(2). Children exposed to cigarette
smoke in utero are more likely than their peers to be born at
<37 weeks of gestation(5), low birth weight, that is, <2·5 kg(6–8),
as still births(9), and with congenital malformations(10). Adverse
perinatal smoking-associated outcomes include alterations in
maternal and child brain structure and function which in turn
adversely impact behaviour; infants born to mothers who
smoke during pregnancy present with smaller head circumfer-
ences(11), structural alterations in the amygdala(12), and volu-
metric reductions in cortical grey matter, the corpus callosum
and frontal, temporal and parietal lobes(13). Exposure to
tobacco smoke in utero is also linked to increased risks of
hyperactive-inattentive behaviour(14), and a 3-fold increased
likelihood of being diagnosed with attention deﬁcit hyper-
activity disorder(15–18). Maternal smoking may impact neuro-
development via several mechanisms including placenta
insufﬁciency, reductions in blood ﬂow and O2 deprivation in
the brain(19) alternations in fetal brain gene expression(20),
Abbreviations: ALSPAC, Avon Longitudinal Study of Parents and Children; HUFA, highly unsaturated fatty acids; IQR, interquartile range.
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altered nicotinic receptors(21) and persistent alterations in neuro-
transmitter activity and turnover(22–24) including an impaired
dopaminergic system. Smoking during pregnancy is likely to
decrease the amount of blood sent to the fetus and hinder the
supply of both nutrition and O2 resulting directly on the brain
of the fetus via tar and carbon monoxide exposure(25,26). It is now
known that nicotine crosses the placenta, enters the fetal
circulation and accrues in the fetal compartments from as early as
7 weeks of gestation(2). Identiﬁcation of novel agents that are safe
and may reduce the burden of smoking is useful.
n-3 Highly unsaturated fatty acids (HUFA) are biophysically
and biochemically essential components of neuronal mem-
branes that are critical for healthy brain development and
optimal neurological function(27). Zaparoli & Galduroz(26) have
posited that n-3 HUFA, including DHA and EPA, may also have
the potential to positively alter smoking behaviours, due to their
role in supporting dopamine mediated reward function. One
double-blind, randomised, placebo-controlled pilot study
reported signiﬁcant reductions in the number of cigarettes
smoked and in tobacco cravings following supplementation
with n-3 compared with placebo(25). A second report found in a
cross-sectional observation study lower levels on n-3 HUFA
among smokers compared with controls and, in a randomised
controlled trial of sixty-three participants for smoking reduction,
found a reduction in nicotine dependence ratings, but no
difference in serum cotinine and self-report consumption(28).
We could identify no prior publications exploring any
relationships between maternal ﬁsh or n-3 consumption and
smoking behaviours, before, during or after pregnancy.
In this study, we examined three questions regarding
potential relationships between consumption of ﬁsh, as a rich
source of n-3 HUFA, and perinatal smoking. We used data
collected with standardised and validated protocols on 9640
mothers from the ALSPAC longitudinal cohort study: (1) was
greater ﬁsh consumption associated with lower risks of
smoking, at pre-conception and in each trimester?, (2) was
greater ﬁsh consumption associated with greater likelihood of
cessation of smoking, after conception, during each trimester?,
and (3) was greater ﬁsh consumption associated with lower
risks of smoking relapse between second and third trimesters,
after pre-partum cessation? We sought to identify and adjust for
confounding variables such as socioeconomic status that could
underlie associations between greater ﬁsh consumption and
healthier smoking behaviours.
Methods
Study population
The ALSPAC is a UK population-based study which aims to
investigate environmental and genetic inﬂuences on the health
and development of children(29,30). Pregnant women residing in
the former Avon Health Authority in South-West England who
had an estimated date of delivery between 1 April 1991 and
31 December 1992 were invited to take part, resulting in a
cohort of 14 541 pregnancies and 13 978 children alive at
12 months of age (excluding triplets and quads). Ethical
approval for this study was obtained from the ALSPAC Law and
Ethics Committee and the Local Research Ethics Committees.
The representative nature of the ALSPAC sample has been
investigated by comparison with the 1991 National Census data
of mothers with infants under 1 year of age who were residents
in the county of Avon. The ALSPAC sample had a slightly
greater proportion of mothers who were married or cohabiting,
who were owner-occupiers and who had a car in the house-
hold. The study had a smaller proportion of ethnic minority
mothers. The ALSPAC study website contains details of all the data
that are available through a fully searchable data dictionary (www.
bris.ac.uk/alspac/researchers/data-access/data-dictionary/).
Reported intake of ﬁsh and n-3 fatty acids
ALSPAC participant mothers completed a self-administered
semi-quantitative FFQ during the third trimester of their preg-
nancy; median gestational age at completion was 32 weeks. As
ﬁsh is the richest source of HUFA, we utilised three questions
from the FFQ relating to ﬁsh consumption: How many times
nowadays do you eat (a) white ﬁsh (cod, haddock, plaice, ﬁsh
ﬁngers, etc.), (b) dark or oily ﬁsh (tuna, sardines, pilchards,
mackerel, herring, kippers, trout, salmon, etc.), and (c) shellﬁsh
(prawns, crabs, cockles, mussels etc.)? as previously descri-
bed(31). Responses to all food questions were used to derive
a measure of total energy intake (in kJ (kcal)).
Fish consumption by weight. Portion sizes were based on
typical eating patterns in the UK with consideration of relative
proportions of processed and fresh ﬁsh commonly con-
sumed(31). Total ﬁsh consumption per week was calculated as
the total number of portions, multiplied by the portion size for
each type of ﬁsh. A mother who ate ﬁsh three times a week
would typically have a ﬁsh intake of 347 g/week (range
297–358 g/week). This continuous measure which was guided
by the US FDA/EPA advice to limit ﬁsh consumption to
340 g/week and was collapsed into a three-category ordinal
measure comprising ‘no ﬁsh consumption’ (coded 0), ‘low
ﬁsh consumption (1–340 g/week)’ (coded 1) ‘and high ﬁsh
consumption (>340 g/week)’ (coded 2)(31).
n-3 Intake. Fatty acid values were based on proﬁles of typical
species of British ﬁsh(32). Intake of n-3 fatty acids for each
portion were estimated as follows: white ﬁsh, 0·32 g; oily ﬁsh,
0·89 g; shellﬁsh, 0·34 g. Derived estimates of the intake of n-3
fats from ﬁsh: α-linolenic acid, EPA, DPA and DHA were
calculated as total amounts and as proportions of total energy
intake. This continuous measure was divided into six categories
comprised of those with zero exposure (no ﬁsh consumption –
coded 0) and ﬁve equally sized groups describing increasing
exposure (coded 1 through 5). The exact cut-points on the
distribution were selected attempting to maintain an adequate
sample within each category and reﬂect clusters in the
frequencies of responses.
Measures of smoking behaviour
Information on tobacco use before and during pregnancy was
collected via a postal questionnaire administered during mid
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pregnancy with further subsequent questionnaires assessing
late-pregnancy and postnatal use. The mid pregnancy ques-
tionnaire (median gestation at completion= 19 weeks gestation,
interquartile range (IQR)= 18–21 weeks) provided three mea-
sures of tobacco use – smoking pre-pregnancy, smoking in ﬁrst
trimester and smoking in second trimester. For each measure,
responses on an ordinal scale determining frequency of
use (cigarettes per d) were collapsed into a binary yes/no
measure. An indicator of smoking in the third trimester was
derived from a further question included in the late-pregnancy
questionnaire which also contained the FFQ mentioned above.
Confounders
Multiple measures described below were considered as
potential confounders for the diet-smoking relationship. These
comprised established risk factors for smoking behaviour for
which we felt the assumption of a causal predictive relationship
with ﬁsh consumption could be justiﬁed. This approach led the
exclusion of certain variables – including maternal mental
health and partner smoking behaviour – which did not fulﬁl this
speciﬁc requirement despite being anticipated to be associated
with both exposure and outcome in our models. Confounders
were included irrespective of their observed impact in the
empirical models.
Socio-demographic measures. Data collected by ques-
tionnaire during the antenatal period comprised: housing
tenure (coded as owned/mortgaged, privately rented, sub-
sidised housing rented from council/housing association),
Maternal educational attainment (coded as no high school
qualiﬁcations, high school, beyond high school) and parity
(coded as whether study child is 1st/2nd/3rd child or greater:
family size being another proxy for socioeconomic status),
Home overcrowding at enrolment (1+ persons per room),
Maternal age at delivery of study child (<20 years, 20–24, 25–29,
30–34, 35–39, 40+ years), ﬁnancial difﬁculties in pregnancy
(scoring in the top centile of a scale derived from ordinal
responses to questions assessing the degree to which the family
have difﬁculties affording food, clothing, heating, rent or
mortgage, and items needed for the baby) and parental social
class (the highest social class of either parent) at enrolment
based on the Registrar General’s classiﬁcation of occupations:
I (professional), II (managerial and technical), IIINM (skilled non-
manual), IIIM (skilled manual) or lower IV/V (semiskilled and
unskilled) and ethnicity of young person (white/non-white).
Indicators of healthy lifestyle. Whilst difﬁcult to measure
accurately, health-consciousness is likely to strongly inﬂuence
both diet and also smoking behaviour. We selected the
following which were felt to tap into this concept. First, the
18-week questionnaire which asked: ‘Compared with other
pregnant women of your age, would you consider yourself to
be: much more active/somewhat more active/about the same/
somewhat less active/much less active’. In addition, the
32-week questionnaire which is also part of the FFQ asks: fre-
quency of consuming herbal teas (often/occasionally/never),
and whether mother often eats/drinks other health foods.
Statistical methods
A series of univariable and multivariable regression models were
estimated using ﬁrst ﬁsh consumption (three-category ordinal)
and second n-3 from ﬁsh (six category ordinal) as the exposure
variable. Regression estimates were derived with reference to the
low ﬁsh consumption and n-3 HUFA-free category respectively.
The binomial family and log-link were employed to derive risk-
ratios given the relatively high number of cases (e.g. rate of
smoking) for some models which would have detrimentally
impacted on the interpretation of estimated OR. Models were
subsequently adjusted for the potential confounding effects of
socio-demographics and additionally health-lifestyle indicators.
A consideration of the use of negative controls in this analysis is
included in the supplementary materials. More details regarding
the analytical approach used to address each aim are given below.
Aim 1: association between n-3/ﬁsh consumption and
smoking status. A series of regression models were derived
predicting smoking status at four different time points (i.e. pre-
pregnancy, early pregnancy, mid pregnancy, late pregnancy).
The sample used for this aim comprised all mothers with
available data.
Aim 2: association between n-3/ﬁsh consumption and
smoking cessation. A series of regression models were derived
predicting smoking cessation at three different time points
(i.e. early pregnancy, mid pregnancy, late pregnancy). The
sample used for this aim comprised all mothers who reported
smoking regularly before the pregnancy.
Aim 3: association between n-3/ﬁsh consumption and
smoking relapse from a state of cessation. A ﬁnal regression
model was derived predicting smoking relapse in the third
trimester of pregnancy. The sample used for this aim comprised
all mothers who reported smoking regularly before the preg-
nancy and subsequent cessation by the second trimester.
Results
Sample derivation
The ALSPAC study enrolled mothers-to-be using a range of
recruitment methods including posters displayed in chemists,
libraries, general practitioner waiting rooms and antenatal
clinics; coverage in the press, on radio and television, and
through contact with midwives. Consequently gestation at
enrolment varied markedly depending on each mother’s use of
these services as well as her own awareness regarding her
pregnancy status. Four questionnaires were administered to
mothers during pregnancy and the timing and ordering of these
questionnaires was determined by gestation at enrolment as set
out in the study protocol. For mothers enrolling late in preg-
nancy, a fewer number of questionnaires were administered
with the more time-sensitive questions removed. The majority
of the analyses in this manuscript required responses from both
the 18-week and 32-week gestation questionnaires. Of a pos-
sible available sample of 13 798, data were available from
10 519 (76·2%) when excluding those who either: (i) failed to
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respond to one of the two questionnaires (n 1865), or (ii)
responded to one or both questionnaires outside of the inten-
ded time window (including after the birth) such that their
responses could be deemed as no longer representative of the
pregnancy periods of interest (n 1414). The online Supple-
mentary Table S1 shows that certain groups, for example,
younger mothers and those from subsidised housing were
under-represented in this sub-sample of 10 519.
Of the sample of 10 519 who returned both questionnaires at
the appropriate time, a total of 9640 (91·6%) respondents
provided information on both antenatal smoking (18 and
32 weeks) and diet, 63 (0·60%) lack information on diet alone,
804 (7·6%) lack information on smoking alone (mainly from the
32-week questionnaire), and 12 (0·11%) lack information both
on diet and smoking. Of concern here was the considerable
number failing to provide information on their third-trimester
smoking behaviour, however there was little evidence of a
difference in n-3 intake from diet for these mothers compared
with members of the sample of 9640 (t test: P= 0·2).
Aim 1: risk of smoking before and during
pregnancy (Table 1; Fig. 1)
Focusing on the sample of 9640 for which univariable
complete-case analyses were possible, a total of 1194 (12·4%)
mothers report no ﬁsh consumption, the majority (6254, 64·9%)
consumed some ﬁsh but <340 g/week and 2192 (22·7%) were
estimated to consume 340 g or more per week.
n-3 Intake via ﬁsh consumption was estimated to account for
between 0 and 0·74% of total energy intake whilst
energy intake per d ranged from 2178·2 to 16 954 kJ (520·6 to
4052 kcal). For those reporting no ﬁsh consumption, the
distribution of energy intake had a median of 6586 kJ (IQR
5385–7904) (1574 kcal (IQR 1287–1889)). For those reporting
<340 g of ﬁsh per week, the distribution of n-3 intake had a
median of 0·046% (IQR 0·025%–0·070%) and the distribution of
energy intake had a median of 7138 kJ (IQR 5899–8431)
(1706 kcal (IQR 1410–2015)). For those reporting ﬁsh con-
sumption equivalent to 340 g or more per week, the distribution
of n-3 intake had a median of 0·17% (IQR 0·13–0·21) and
the distribution of energy intake had a median of 7791 kJ
(IQR 6611–9104) (1862 kcal (IQR 1580–2176)).
Categorisation of continuous n-3 measure from ﬁsh in diet
(en%) was as follows: one group comprised of the 1194 (12·4%)
reporting no ﬁsh consumption and ﬁve equal groups of 17·5%
of the sample captured increasing levels of exposure. Five
equally sized groups of those exposed to n-3 through ﬁsh in
diet correspond to the following range of values: group 1
(median= 0·013%, range= 0·006–0·030), group 2 (median=
0·042%, range= 0·030–0·050), group 3 (median= 0·061%,
range= 0·050–0·078), group 4 (median= 0·110%, range=
0·078–0·150), group 5 (median= 0·190%, range= 0·150–0·740).
Fish consumption. In all, 3044 (31·6%) reported smoking
before the pregnancy. This reduced to 2260 (23·4%) in the ﬁrst
trimester, 1789 (18·6%) in the second trimester with a slight rise
to 1905 (19·8%) in the third trimester. The estimated association
between ﬁsh consumption and risk of smoking is shown in
Table 1. Before adjustment for confounders, there was strong
evidence (P< 0·001) of a large negative association between
ﬁsh consumption and smoking. Lower ﬁsh consumption
(<340 g/week) was associated with a 25% lower risk of smoking,
whilst high ﬁsh consumption (340 g + /week) was associated with
a 50% lower risk. Whilst the prevalence of smoking in the
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Fig. 1. Cumulative percentage of smoking in pregnancy by n-3 fatty acid consumption. The relationships between levels of n-3 consumption and the cumulative
percentage of women in each smoking category at 32 weeks gestation are illustrated. , Number of women at each level of n-3 fatty acid intake from fish; coloured
lines identify each smoking category defined by amount of cigarette consumption. The increasing cumulative percentages of women within each smoking category are
indicated as a response to increasing n-3 intake. , a cumulative threshold of 50% of women detected within each smoking category. The intersection of the
dashed line with each of the coloured lines, indicates the n-3 value for the median split of women in each smoking category. For example, a consumption level of 0·01
energy percentage (en%) n-3 accounts for 50% of women in the smoking category of 20–24+ cigarettes/d. In contrast, a consumption level of 0·06 en% level of n-3
accounts for 50% of women in the smoking category of 0 cigarettes/d. The right-hand panel is an expanded view identifies the specific levels of n-3 intake where the
50% threshold is reached within each smoking category and indicates that higher levels of n-3 intake are associated with less smoking in pregnancy in a dose–
response relationship. Cigarette consumption: , 0/d (n 7735); , 1–4/d (n 300); , 5–9/d (n 458); , 10–14/d (n 535); , 15–19/d (n 317);
, 20–24/d (n 230); , 25 + /d (n 65).
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population diminished, from a high of 31·6% (pre-pregnancy) to
a low of 18·7% (second trimester), the magnitude of effects for
ﬁsh consumption were stable. Adjustment for confounders led to
a substantial attenuation in the effect estimates, however there
remained fairly strong evidence (P values in range 0·011–0·001)
of a moderate beneﬁcial effect of ﬁsh consumption, particularly
for those who consumed 340 g or more per week where risk of
smoking is approximately 20% lower. Further investigation
revealed that the confounders producing the greatest parameter
attenuation were socio-demographics – maternal education,
maternal age, social class and housing tenure.
n-3 Highly unsaturated fatty acids. There was good support
for a linear relationship (dose–response) between categories of
estimated n-3 intake from ﬁsh (as % energy) and risk of smoking
(further details are available in the online Supplementary
Appendix). Table 1 shows the estimated linear effect, namely the
reduction in risk per category increase in n-3. Results mirror those
for ﬁsh consumption with a moderate beneﬁt in terms of reduced
smoking risk for each category increase in n-3 exposure.
Aim 2: likelihood of smoking cessation in
pregnancy (Table 2)
The likelihood of smoking cessation among those mothers
previously reporting tobacco use was examined. The starting
sample for these analyses was the 3044 (31·6%) reporting
smoking regularly before the pregnancy. As expected, the rates
of ﬁsh consumption among this subgroup were slightly lower: a
total of 505 (16·6%) reported no ﬁsh consumption, 2021
(66·4%) consumed some ﬁsh, but <340 g/week and 518
(17·0%) consumed 340 g or more per week.
Fish consumption. Cessation rates increased between trimes-
ters 1 and 2 (from 26·1% to 41·5%), before reducing slightly to
38·6% in trimester 3 as some mothers relapse again. There was
strong evidence (P≤ 0·002) for a moderate positive association
between ﬁsh consumption and smoking cessation amongst this
subgroup of recent regular smokers (Table 2). Adjustment for
potential confounders once again leads to substantial
attenuation.
n-3. An identical pattern was found here: (i) the change in risk
of cessation is essentially monotonic across categories of n-3
(online Supplementary Appendix), (ii) the results mirrored
those for ﬁsh consumption with lower P values here due to
increased power.
Aim 3: risk of smoking relapse in mid pregnancy (Table 3)
Aim 3 focused on a relapse in smoking between the second and
third trimester, that is, members of the sample reported smoking
regularly before pregnancy and were not smoking in the
second trimester (n 1264). A total of 237 were smoking when
Table 1. Aim 1, n-3 exposure/fish consumption and smoking (complete-case analyses)
(Numbers and percentages; odds ratios and 95% confidence intervals)
Smoking Unadj-RR (n 9640) Adj-RR1 (n 8747) Adj-RR2 (n 8102)
Outcomes Exposure n % OR 95% CI OR 95% CI OR 95% CI
Smoking pre-pregnancy Fish consumption
None 505 42·3 1·00 Ref. 1·00 Ref. 1·00 Ref.
<340g/week 2021 32·3 0·76 0·71, 0·82 0·95 0·88, 1·02 0·94 0·87, 1·02
340 g/week + 518 23·6 0·56 0·51, 0·62 0·84 0·76, 0·93 0·84 0·75, 0·94
P< 0·001 P=0·004 P=0·008
Linear effect of n-3 from fish (en%) 0·88 0·87, 0·90 0·96 0·95, 0·98 0·96 0·94, 0·98
P< 0·001 P<0·001 P<0·001
Smoking in 1st trimester Fish consumption
None 396 33·2 1·00 Ref. 1·00 Ref. 1·00 Ref.
<340g/week 1510 24·1 0·73 0·66, 0·66 0·92 0·83, 1·01 0·92 0·83, 1·02
340 g/week + 354 16·2 0·49 0·49, 0·55 0·78 0·68, 0·89 0·80 0·69, 0·92
P< 0·001 P=0·002 P=0·011
Linear effect of n-3 from fish (en%) 0·85 0·83, 0·87 0·94 0·92, 0·97 0·95 0·92, 0·97
P< 0·001 P<0·001 P<0·001
Smoking in 2nd trimester Fish consumption
None 324 27·1 1·00 Ref. 1·00 Ref. 1·00 Ref.
<340g/week 1188 19·0 0·70 0·63, 0·78 0·87 0·77, 0·99 0·89 0·78, 1·01
340 g/week + 277 12·6 0·47 0·40, 0·54 0·72 0·61, 0·85 0·75 0·63, 0·90
P< 0·001 P<0·001 P=0·009
Linear effect of n-3 from fish (en%) 0·84 0·82, 0·87 0·93 0·90, 0·96 0·94 0·91, 0·97
P< 0·001 P<0·001 P<0·001
Smoking in 3rd trimester Fish consumption
None 353 29·6 1·00 Ref. 1·00 Ref. 1·00 Ref.
<340g/week 1261 20·2 0·68 0·62, 0·75 0·88 0·79, 0·99 0·87 0·77, 0·97
340 g/week + 291 13·3 0·45 0·39, 0·52 0·73 0·62, 0·85 0·73 0·61, 0·86
P< 0·001 P<0·001 P=0·001
Linear effect of n-3 from fish (en%) 0·84 0·82, 0·86 0·93 0·90, 0·96 0·93 0·91, 0·96
P< 0·001 P<0·001 P<0·001
RR, relative risk; Adj-RR1, adjustment for socio-demographics, that is maternal education, maternal age at delivery, housing tenure, home overcrowding, birth order, parental
highest social class, financial problems in pregnancy and child ethnicity; Adj-RR2, further adjustment made for indicators of a healthy lifestyle, that is perception of activity levels in
early pregnancy compared with peers, consumption of herbal tea and health foods in late pregnancy; Ref., referent values; en%, energy percentage.
Maternal ﬁsh consumption during pregnancy 5
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0007114517003592
Downloaded from https://www.cambridge.org/core. University of Bristol Library, on 02 May 2018 at 08:48:20, subject to the Cambridge Core terms of use, available at
asked subsequently at 32 weeks gestation giving a relapse rate
of 18·8%. Fish consumption in this subgroup was slightly higher
than that for Aim 2: 183 (14·5%) reported no ﬁsh consumption,
838 (66·3%) consumed some ﬁsh but <340 g per week and 243
(19·2%) consumed 340 g or more per week (Table 3).
Whilst ﬁsh consumption and in particular >340 g/week was
protective against smoking relapse in the unadjusted analyses,
the results attenuated substantially following adjustment for
confounders leaving little evidence of any beneﬁcial effect in
the multivariable models.
Discussion
Summary of ﬁndings
Here we found that among pregnant women in the UK, greater
ﬁsh consumption had a modest, but consistent association with
lower risk of smoking in the perinatal period and in all three
trimesters of pregnancy. These associations had a clear dose–
response relationship concordant with modelling protective
levels of n-3 HUFA intake , with a 4–7% reduction in pre-
valence for each increasing quintile of n-3 HUFA intake, relative
to mothers who reported never eating ﬁsh. Consumption of
greater than 340 g ﬁsh per week was consistently associated
with beneﬁcial smoking behaviours. These ﬁnding persisted
after controlling for both socio-demographic factors and
indicators of healthy life-style practices.
The prevalence of smoking decreased as weeks of gestation
increased from approximately 32% pre-pregnancy as to a
low of 19% during the second trimester. However, despite
this reduction in smoking rates across trimester, the magnitude
of protective effects for ﬁsh consumption were consistent.
Protective relationships, similar in magnitude and direction,
were observed for ﬁsh consumption and smoking cessation
Table 2. Aim 2 – n-3 exposure/fish consumption and smoking cessation (complete-case analyses)
(Numbers and percentages; odds ratios and 95% confidence intervals)
Not smoking Unadj-RR (n 3044) Adj-RR1 (n 2615) Adj-RR2 (n 2402)
Outcome n-3 Exposure n % OR 95% CI OR 95% CI OR 95% CI
Cessation in 1st trimester Fish consumption
None 111 22·0 1·00 Ref. 1·00 Ref. 1·00 Ref.
<340g/week 517 25·6 1·16 0·97, 1·39 1·02 0·84, 1·24 1·02 0·83, 1·25
340 g/week+ 166 32·0 1·46 1·19, 1·79 1·23 0·98, 1·53 1·16 0·92, 1·47
P<0·001 P= 0·042 P=0·214
Linear effect of n-3 from fish (en%) 1·10 1·06, 1·14 1·06 1·02, 1·11 1·04 1·00, 1·08
P<0·001 P= 0·004 P=0·082
Cessation in 2nd trimester Fish consumption
None 183 36·2 1·00 Ref. 1·00 Ref. 1·00 Ref.
<340g/week 838 41·5 1·14 1·01, 1·30 1·07 0·94, 1·23 1·07 0·93, 1·23
340 g/week+ 243 46·9 1·29 1·12, 1·50 1·17 1·00, 1·37 1·12 0·95, 1·31
P=0·002 P= 0·109 P=0·384
Linear effect of n-3 from fish (en%) 1·06 1·04, 1·09 1·04 1·01, 1·07 1·02 0·99, 1·05
P<0·001 P= 0·007 P=0·110
Cessation in 3rd trimester Fish consumption
None 162 32·1 1·00 Ref. 1·00 Ref. 1·00 Ref.
<340g/week 777 38·5 1·20 1·04, 1·38 1·06 0·92, 1·23 1·09 0·95, 1·27
340 g/week+ 235 45·6 1·41 1·21, 1·66 1·18 1·01, 1·39 1·13 0·96, 1·34
P<0·001 P= 0·076 P=0·341
Linear effect of n-3 from fish (en%) 1·08 1·06, 1·11 1·04 1·01, 1·07 1·03 1·00, 1·06
P<0·001 P= 0·003 P=0·086
RR, relative risk; Adj-RR1, adjustment for socio-demographics, that is maternal education, maternal age at delivery, housing tenure, home over-crowding, birth order, parental
highest social class, financial problems in pregnancy and child ethnicity; Adj-RR2, further adjustment made for indicators of a healthy lifestyle, that is perception of activity levels in
early pregnancy compared with peers, consumption of herbal tea and health foods in late pregnancy; Ref., referent values; en%, energy percentage.
Table 3. Aim 3 – relapse model, n-3/fish consumption and relapse between second and third trimester (complete-case analyses)
(Numbers and percentages; odds ratios and 95% confidence intervals)
Relapsed Unadj-RR (n 1264) Adj-RR1 (n 1125) Adj-RR2 (n 1024)
Exposures n % OR 95% CI OR 95% CI OR 95% CI
Fish consumption
None 46 25·1 1·00 Ref. 1·00 Ref. 1·00 Ref.
<340g/week 155 18·5 0·74 0·55, 0·98 0·98 0·57, 1·66 0·99 0·56, 1·73
340g/week + 36 14·8 0·59 0·40, 0·87 0·89 0·47, 1·68 0·92 0·39, 2·19
P=0·023 P=0·903 P=0·966
Linear effect of n-3 from fish (en%) 0·89 0·84, 0·96 0·97 0·87, 1·09 0·99 0·85, 1·16
P=0·001 P=0·607 P=0·919
RR, relative risk; Adj-RR1, adjustment for socio-demographics, that is maternal education, maternal age at delivery, housing tenure, home over-crowding, birth order, parental
highest social class, financial problems in pregnancy and child ethnicity; Adj-RR2, further adjustment made for indicators of a healthy lifestyle, that is perception of activity levels in
early pregnancy compared with peers, consumption of herbal tea and health foods in late pregnancy; Ref., referent values; en%, energy percentage.
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across trimesters. However, although these relationships were
robust to adjustment for confounding by socio-demographics
factors, they were not robust to further adjustment by
factors speciﬁcally indicative of a healthy lifestyles. Thus, ﬁsh
consumption may have been an indicator of greater overall
health conscious behaviours, including less smoking.
Given the well-established risks of harm from maternal
smoking including missing or deformed limbs, cleft palate,
premature birth and cot death(2), the possible identiﬁcation of
any intervention with a safe an beneﬁcial proﬁle with potential
to reduce smoking during pregnancy, is useful. Rabinovitz
et al.(25) recently reported a signiﬁcant decrease in self-reported
daily smoking and tobacco cravings in regular cigarette smokers
(n 48) consuming 2710mg of EPA and 2040mg of DHA daily
for one month in the context of a randomised, placebo-
controlled pilot study(25). Currently, the main pharmacological
treatments for smoking cessation include bupropion (dopamine
reuptake inhibitor), varenicline (partial agonist of nicotine
receptors), nicotine replacement therapy and electronic cigar-
ettes (non-prescribed). All present with side-effects including
disrupted sleep, headaches, nausea, tachycardia and dry
mouth(26). The effectiveness of these therapies for pregnant
mothers has been reported as limited in many systematic
reviews. In 2012 Cochrane report reviewed thirty-two phar-
macologic agents for smoking cessation but found insufﬁcient
evidence to permit conclusions about beneﬁts and harms(33). In
contrast, the safety proﬁle of ﬁsh an n-3 fatty acids in pregnancy
have been well described. The Food Drug Agency (FDA)
currently advises that that dietary dosage of up to 3 g/d of n-3
fatty acids from marine sources are ‘generally recognised as
safe’. While the European Food Standards Authority have set a
safe upper limit of 5 g/person per d for total amounts of the n-3
fatty acids: DHA, EPA and DPA.
Potential biological mechanisms
The mechanisms of how n-3 HUFA and nutrients rich in ﬁsh
might impact the neurobiology underlying tobacco use and
addictive processes are complex; more than eighteen neuro-
transmitter systems across multiple neurotransmitter systems
and brain regions involving multiple stages of development of
drug-seeking habits and maintenance(34). Dietary deﬁcits in n-3
HUFA appear to contribute to many of these central char-
acteristics of the chronic addicted state including; deﬁcits in
dopaminergic components of the reward system(35–38), hyper-
activity of the endocannabinoid system(39,40), impaired neuro-
genesis(41,42) and excessive recruitment of brain stress
neurotransmitters, including corticotropin-releasing factor(43,44)
expressed in the neurocircuitry of the extended amygdala. DHA
is enriched throughout neuronal members and especially con-
centrated among cortical grey matter and in brain regions
including the corpus callosum, frontal, temporal and parietal
lobes, and amygdala(45,46). Most of the accumulation of
DHA takes place during prenatal and early postnatal develop-
ment(41,42,45,47) and n-3 HUFA are implicated in neurogenesis,
synaptogenesis, and myelination(41,42).
Both DHA and EPA have modulating effects on dopaminergic
and serotonergic systems and in animal models chronic n-3
HUFA deﬁciency results in marked alterations in dopamine-
related neurotransmission and behaviour(35–38). Low n-3
impacts dopamine neurotransmission resulting in hypo-
functioning of the mesocorticial systems associated with reward
and dependence(35). Conversely, restoration and elevation of
n-3 is able to reverse deﬁcits in dopaminergic and serotonergic
neurotransmitter function(36). This diminished function of the
mescocortical systems may contribute to increased craving
responses and thus negatively interfere with smoking cessation
attempts(25,26). Deﬁcits in dopaminergic, serotinergic neuro-
transmission and hyper-responsive stress reactivity mediated by
corticotrophin releasing factor are associated with increased
risks of negative affective emotional states that mediate
increased risk of relapse to substance use(48–51).
Strengths and limitations of study. The major strength of the
study is the large sample size and the careful controlling of
confounding variables. There are some limitations of note,
namely, limits inherent in food frequency questionnaires, the
potential of misclassiﬁcation in measurements and the self-
report smoking records. We recognise also that the chrono-
logical order of data collection is imperfect. Speciﬁcally, data on
the predictive variable, ﬁsh consumption, was collected at
32 weeks, whereas data on dependent variable of smoking
behaviours were collected before this time point. However, as
dietary habits are relatively consistent across time so too ﬁsh
consumption is likely consistent. We wish to emphasise that
residual confounding and reverse causality cannot be ruled out.
Thus, we cannot establish with certainty, any causal relation-
ships demonstrating efﬁcacy between ﬁsh or n-3 consumption
and more beneﬁcial smoking behaviours.
Conclusion
Here we found modest but consistent evidence of a beneﬁcial
association between ﬁsh consumption during pregnancy and
more beneﬁcial smoking behaviours during pregnancy, after
evaluation and adjustment for confounding variables. Lower
risks of adverse smoking behaviours were found among
mothers consuming 340 g or more per week. We suspect that
n-3 HUFA may substantially contribute to this association these
agents, or greater ﬁsh consumption can be considered for
evaluation in secondary and tertiary preventive intervention
trials for smoking in pregnant women. A recent study reporting
lower n-3 HUFA among non-pregnant smokers is consistent
with this interpretation(52). These ﬁndings may provide a basis
of support for the conduct of randomised controlled trials
designed to evaluate if greater ﬁsh consumption, or nutrients
rich in ﬁsh such as n-3 fatty acids, has clinical efﬁcacy in
improving smoking cessation or in reducing risk of smoking.
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